Key Lessons on Building a Life Science Company: Raising capital and more with Neil Klompas, CFO of Zymeworks.

OBIO invites you this incredible opportunity to join us and to learn more about Zymeworks Inc., a privately held Canadian biotherapeutics company with operations in Vancouver, Montréal and Seattle, developing first-in-class and best-in-class bispecific antibodies and protein therapeutics for the treatment of cancer and other areas of unmet medical need.  

In person over breakfast and by webinar, Zymeworks’ CFO Neil Klompas will provide an overview of the Company, describe their agility in adjusting their business and product development pipeline, and how they worked with the Canadian and U.S. investor communities to secure more than C$178M in financing, including a recent round of US$62M from strategic partners, venture funds and other institutional investors.  

Highlights and takeaways include:
•    How Zymeworks pivoted from focusing on industrial enzymes to developing antibody therapeutics,
•    The financing road to date, from targeting Angel investors to their most recent cross-border financing, 
•    How Zymeworks has been successful in securing partnerships with leading global pharmaceutical partners including Merck, Eli Lilly, Celgene, and GSK, and
•    Key wins and hiccups along the road, as well as plans for the future!

Zymeworks is developing a pipeline of potentially game-changing therapeutics across multiple oncology indications by leveraging its bi-specific and multivalent antibody therapeutics platforms (Azymetric™, AlbuCORE™, EFECT™), and its newly acquired antibody-drug conjugate platforms, (ZymeLink™). 

Join us and ask your questions! 

Neil Klompas, CPA, CA has over 20 years of healthcare and biotech experience in corporate finance, compliance, operations and financial reporting.  Prior to joining Zymeworks, Neil was with KPMG’s Biotechnology and Pharmaceutical practices both in the U.S. and Canada. Neil holds a Chartered Professional Accountant (Chartered Accountant) designation, as well as a BSc in Microbiology and Immunology from UBC.